Current Heart Failure Reports

Scope & Guideline

Navigating the Complexities of Heart Failure

Introduction

Explore the comprehensive scope of Current Heart Failure Reports through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Current Heart Failure Reports in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1546-9530
PublisherSPRINGERNATURE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2004 to 2024
AbbreviationCURR HEART FAIL REP / Curr. Heart Fail. Rep.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Current Heart Failure Reports focuses on the multifaceted nature of heart failure, including its pathophysiology, diagnosis, treatment, and management strategies. The journal emphasizes the integration of clinical research and innovative methodologies to enhance patient outcomes.
  1. Clinical Management and Treatment Strategies:
    The journal explores various therapeutic interventions and management strategies for heart failure, focusing on both pharmacological and non-pharmacological approaches.
  2. Biomarkers and Diagnostic Tools:
    A significant emphasis is placed on identifying and validating biomarkers for diagnosing and monitoring heart failure, which aids in tailoring individualized treatment plans.
  3. Multimorbidity and Comorbid Conditions:
    Current Heart Failure Reports addresses the complexities of managing heart failure in patients with multiple comorbidities, highlighting the need for a multidisciplinary approach.
  4. Emerging Technologies and Innovations:
    The journal covers advancements in technology, including digital health solutions and novel therapeutic modalities, aimed at improving heart failure management.
  5. Sex and Gender Differences:
    An ongoing focus on understanding how sex and gender influence heart failure pathophysiology, treatment responses, and outcomes is a hallmark of the journal.
  6. Research on Special Populations:
    The journal includes research specifically addressing heart failure in unique populations such as the elderly, pregnant women, and patients with cancer.
Current Heart Failure Reports is evolving to include new and significant themes that reflect current challenges and advancements in the field of heart failure. This section outlines the emerging and trending areas of research.
  1. Biomarkers and Precision Medicine:
    There is a growing focus on the identification and application of biomarkers for precision medicine in heart failure, allowing for better patient stratification and personalized therapies.
  2. Impact of Comorbidities on Heart Failure:
    Emerging research highlights the importance of understanding how comorbid conditions, such as diabetes and cancer, affect heart failure management and patient outcomes.
  3. Digital Health and Telemedicine:
    The integration of digital health technologies and telemedicine in managing heart failure is an increasingly prominent theme, especially in light of the COVID-19 pandemic.
  4. Sex and Gender Disparities:
    Research addressing sex and gender differences in heart failure is gaining traction, focusing on how these factors influence disease mechanisms, treatment efficacy, and clinical outcomes.
  5. Innovative Therapeutic Approaches:
    There is an increasing trend towards exploring novel therapeutic avenues, including gene therapy, cellular therapies, and advanced device technologies for heart failure management.
  6. Mental Health and Heart Failure:
    The recognition of mental health's role in heart failure, including depression and anxiety, is an emerging area of focus, emphasizing the need for comprehensive care.

Declining or Waning

While Current Heart Failure Reports maintains a broad spectrum of topics, certain areas of research appear to be declining in prominence over recent years. This section highlights those waning themes.
  1. Traditional Risk Factor Management:
    Research focusing solely on traditional cardiovascular risk factors (like hypertension and hyperlipidemia) without considering their interplay with heart failure has become less prominent, as the field shifts towards more integrated approaches.
  2. Basic Science Without Clinical Application:
    There seems to be a decline in purely basic science studies that do not translate into clinical applications or implications for patient management.
  3. Single-Disease Focus:
    The emphasis on heart failure as an isolated condition without considering its relationship with other diseases and comorbidities is waning, as the current research paradigm increasingly appreciates the interconnectedness of health issues.

Similar Journals

Journal of Cardiovascular Medicine

Pioneering Insights for a Healthier Heart
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

World Journal of Cardiology

Advancing cardiovascular knowledge for a healthier world.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.

Radiology-Cardiothoracic Imaging

Pioneering Research in Cardiothoracic Radiology
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-6135Frequency: 6 issues/year

Radiology-Cardiothoracic Imaging, published by the Radiological Society of North America (RSNA), is a leading peer-reviewed journal dedicated to advancing knowledge in the field of cardiothoracic radiology. With an ISSN of 2638-6135 and a remarkable 2023 Scopus ranking of #5 out of 333 in its category, the journal stands out in the Q1 tier for Radiology, Nuclear Medicine, and Imaging, showcasing its significant impact and high-quality research contributions. The journal is committed to providing an open platform for innovative research, insightful reviews, and clinical studies that address the complexities of cardiothoracic imaging, thereby facilitating the enhancement of diagnostic and therapeutic strategies. Operating out of Oak Brook, Illinois, the journal aims to engage a diverse audience of researchers, professionals, and students, fostering collaboration and knowledge exchange within this vital area of radiological science. With a convergence of years extending from 2019 to 2024, Radiology-Cardiothoracic Imaging remains at the forefront of emerging trends and findings, making it an essential resource for anyone passionate about the evolving landscape of cardiothoracic imaging.

Circulation-Heart Failure

Advancing cardiac knowledge for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3289Frequency: 12 issues/year

Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.

International Journal of Cardiology

Leading the Charge in Heart Health Innovations
Publisher: ELSEVIER IRELAND LTDISSN: 0167-5273Frequency: 24 issues/year

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

Journal of the Saudi Heart Association

Pioneering Insights in Cardiovascular Medicine Since 2009
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

Heart Failure Clinics

Elevating Standards of Care in Cardiovascular Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7136Frequency: 4 issues/year

Heart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.

Netherlands Heart Journal

Bridging Research and Practice in the World of Cardiovascular Medicine
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

International Heart Journal

Driving Progress in Cardiology and Patient Outcomes
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.